Grant: Engage Grants Program
McGill University
$25,000.00
Models of vessel calcification
FY 2018-19
Summary
Complete occlusion of the vasculature by mineralised plaques is extremely difficult to treat and prevents the*use of stents that are routinely used to restore flow to narrowed vessels. The partner of this Engage proposal*has a revolutionary CE marked shockwave technology that can safely pierce the calcified obstruction enabling*traditional stenting. This technology then can erradicate the need for some coronary and peripheral bypasses*thereby vastly improving quality of life for many patients with criovascular disease.*In order to work on second and third generation products, having a model of calcified vessels will be of great*value since currently only diseased human tissues and some animal vessels from models of diseases are*available. Clearly there are practical issues surrounding the use of donor human tissues and animal models of*atherosclerosis require considerable time to develop.*The PI is familiar with several techniqes to induce rapid mineralisaton is a variety of natural and synthetic*polymers and will identify routes to rapidly mineralizing femoral arteries harvested from already dead animals*to produce mimics of the human diseased condition. This will afford Soundbite Medical a tool to screen*various configurations of their hardware, thereby accelerating devlopment of better tools for these patients.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
526730-2018
Name nom
Barralet, Jake
Department département
Dentistry, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
1
Nb partie
1
Application title
Models of vessel calcification
Keyword
NSERC
Application summary
Complete occlusion of the vasculature by mineralised plaques is extremely difficult to treat and prevents the*use of stents that are routinely used to restore flow to narrowed vessels. The partner of this Engage proposal*has a revolutionary CE marked shockwave technology that can safely pierce the calcified obstruction enabling*traditional stenting. This technology then can erradicate the need for some coronary and peripheral bypasses*thereby vastly improving quality of life for many patients with criovascular disease.*In order to work on second and third generation products, having a model of calcified vessels will be of great*value since currently only diseased human tissues and some animal vessels from models of diseases are*available. Clearly there are practical issues surrounding the use of donor human tissues and animal models of*atherosclerosis require considerable time to develop.*The PI is familiar with several techniqes to induce rapid mineralisaton is a variety of natural and synthetic*polymers and will identify routes to rapidly mineralizing femoral arteries harvested from already dead animals*to produce mimics of the human diseased condition. This will afford Soundbite Medical a tool to screen*various configurations of their hardware, thereby accelerating devlopment of better tools for these patients.